Interpreting Outcome Data in Hematological Malignancies: A Paradigm for Clinical Studies

por Rowe, Jacob M.
Publicado em 2013

Forward into the second century of Haematologica

por Rowe, Jacob M.
Publicado no Haematologica (2020)

Pathogenesis and prognostication in acute lymphoblastic leukemia

por Zuckerman, Tsila, Rowe, Jacob M.
Publicado em 2014

The myth of the second remission of acute leukemia in the adult

por Forman, Stephen J., Rowe, Jacob M.
Publicado em 2013

How I treat acute myeloid leukemia presenting with preexisting comorbidities

por Ofran, Yishai, Tallman, Martin S., Rowe, Jacob M.
Publicado no Blood (2016)

Efficacy and Safety Profile of Ivosidenib in the Management of Patients with Acute Myeloid Leukemia (AML): An Update on the Emerging Evidence

por Stemer, Galia, Rowe, Jacob M, Ofran, Yishai
Publicado no Blood Lymphat Cancer (2021)

A randomized trial of washed red blood cell and platelet transfusions in adult acute leukemia [ISRCTN76536440]

por Blumberg, Neil, Heal, Joanna M, Rowe, Jacob M
Publicado em 2004

Daratumumab for relapsed/refractory Philadelphia-positive acute lymphoblastic leukemia

por Ganzel, Chezi, Kharit, Mira, Duksin, Chen, Rowe, Jacob M.
Publicado no Haematologica (2018)

Patterns of Information-Seeking for Cancer on the Internet: An Analysis of Real World Data

por Ofran, Yishai, Paltiel, Ora, Pelleg, Dan, Rowe, Jacob M., Yom-Tov, Elad
Publicado em 2012

Assessment of the consistency and robustness of results from a multicenter trial of remission maintenance therapy for acute myeloid leukemia

por Buyse, Marc, Squifflet, Pierre, Lucchesi, Kathryn J, Brune, Mats L, Castaigne, Sylvie, Rowe, Jacob M
Publicado em 2011

Pseudotumor cerebri in acute promyelocytic leukemia patients on Intergroup Protocol 0129: clinical description and recommendations for new diagnostic criteria

por Coombs, Catherine C., DeAngelis, Lisa M., Feusner, James H., Rowe, Jacob M., Tallman, Martin S.
Publicado no Clin Lymphoma Myeloma Leuk (2015)

Leukemia-free survival as a surrogate end point for overall survival in the evaluation of maintenance therapy for patients with acute myeloid leukemia in complete remission

por Buyse, Marc, Michiels, Stefan, Squifflet, Pierre, Lucchesi, Kathryn J., Hellstrand, Kristoffer, Brune, Mats L., Castaigne, Sylvie, Rowe, Jacob M.
Publicado em 2011

ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA WHO ACHIEVE COMPLETE REMISSION AFTER ONE OR TWO CYCLES OF INDUCTION HAVE A SIMILAR PROGNOSIS: A REPORT ON 1,980 PATIENTS REGISTERED TO SI...

por Rowe, Jacob M., Kim, Haesook T., Cassileth, Peter A., Lazarus, Hillard M., Litzow, Mark R., Wiernik, Peter H., Tallman, Martin S.
Publicado em 2010

PHASE II STUDY OF INTERLEUKIN-4 IN INDOLENT B-CELL NON-HODGKIN’S LYMPHOMA AND B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: A STUDY OF THE EASTERN COOPERATIVE ONCOLOGY GROUP (E5Y92)

por Wiernik, Peter H., Dutcher, Janice P., Yao, Xiaopan, Venkatraj, Usha, Falkson, Carla I., Rowe, Jacob M., Cassileth, Peter A.
Publicado em 2010

A functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hod...

por Dann, Eldad J., Bar-Shalom, Rachel, Tamir, Ada, Epelbaum, Ron, Avivi, Irit, Ben-Shachar, Menachem, Gaitini, Diana, Rowe, Jacob M.
Publicado em 2010

An activating intragenic deletion in NOTCH1 in human T-ALL

por Haydu, J. Erika, De Keersmaecker, Kim, Duff, Mary Kaye, Paietta, Elisabeth, Racevskis, Janis, Wiernik, Peter H., Rowe, Jacob M., Ferrando, Adolfo
Publicado em 2012

Lenalidomide and prednisone for myelofibrosis: Eastern Cooperative Oncology Group (ECOG) phase 2 trial E4903

por Mesa, Ruben A., Yao, Xiaopan, Cripe, Larry D., Li, Chin Yang, Litzow, Mark, Paietta, Elisabeth, Rowe, Jacob M., Tefferi, Ayalew, Tallman, Martin S.
Publicado em 2010

Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia

por Van Vlierberghe, Pieter, Ambesi-Impiombato, Alberto, De Keersmaecker, Kim, Hadler, Michael, Paietta, Elisabeth, Tallman, Martin S., Rowe, Jacob M., Forne, Carles, Rue, Montserrat, Ferrando, Adolfo A.
Publicado em 2013

Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid

por Park, Jae H., Qiao, Baozhen, Panageas, Katherine S., Schymura, Maria J., Jurcic, Joseph G., Rosenblat, Todd L., Altman, Jessica K., Douer, Dan, Rowe, Jacob M., Tallman, Martin S.
Publicado em 2011

Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial...

por Cripe, Larry D., Uno, Hajime, Paietta, Elisabeth M., Litzow, Mark R., Ketterling, Rhett P., Bennett, John M., Rowe, Jacob M., Lazarus, Hillard M., Luger, Selina, Tallman, Martin S.
Publicado em 2010